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Abstract
Genetic epidemiologists routinely assess disease susceptibility in relation to hap-
lotypes, i.e., combinations of alleles on a single chromosome. We study statis-
tical methods for inferring haplotype-related disease risk using SNP genotype
data from matched case-control studies, where controls are individually matched
to cases on some selected factors. Assuming a logistic regression model for
haplotype-disease association, we propose two conditional likelihood approaches
that address the issue that haplotypes cannot be inferred with certainty from SNP
genotype data (phase ambiquity). One approach is based on the likelihood of dis-
ease status conditioned on the total number of cases, genotypes, and other covari-
ates within each matching stratum, and the other is based on the joint likelihood
of disease status and genotypes conditioned only on the total number of cases
and other covariates. The joint-liklihood approach is generally more efficient,
particularly for assessing haplotype-environment interactions. Simulation studies
demonstrated that the first approach was more robust to model assumptions on the
the diplotype distribution conditioned on environmental risk variables and match-
ing factors in the control population. We applied the two methods to analyze a
matched case-control study of prostate cancer.
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SUMMARY. Genetic epidemiologists routinely assess disease susceptibility in relation to
haplotypes, i.e., combinations of alleles on a single chromosome. We study statistical methods
for inferring haplotype-related disease risk using SNP genotype data from matched case-control
studies, where controls are individually matched to cases on some selected factors. Assuming
a logistic regression model for haplotype-disease association, we propose two conditional likeli-
hood approaches that address the issue that haplotypes cannot be inferred with certainty from
SNP genotype data (phase ambiguity). One approach is based on the likelihood of disease
status conditioned on the total number of cases, genotypes, and other covariates within each
matching stratum, and the other is based on the joint likelihood of disease status and genotypes
conditioned only on the total number of cases and other covariates. The joint-likelihood ap-
proach is generally more efficient, particularly for assessing haplotype-environment interactions.
Simulation studies demonstrated that the first approach was more robust to model assumptions
on the diplotype distribution conditioned on environmental risk variables and matching factors
keywords: conditional likelihood; logistic regression; matched case-control study; phase ambiguity; unphased
genotype data.
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in the control population. We applied the two methods to analyze a matched case-control study
of prostate cancer.
1. Introduction
To assess the association between a disease outcome and a candidate gene using genotype data
for single nucleotide polymorphisms (SNPs), it has been generally agreed that the disease risk
in relation to the set of alleles on each chromosome (haplotype), should be examined (Risch
and Merikangas, 1996; Botstein and Risch, 2003; Schaid, 2004). Haplotype-based association
analysis has been proven to be useful when alleles on the same chromosome interact with each
other (cis interaction) or for fine mapping of disease causing loci (Schaid, 2004). When studies
involve unrelated individuals, however, the haplotypes may not be inferred with certainty from
the multi-locus SNP genotype data. This phenomenon is usually referred to as phase ambi-
guity. To address this issue, various statistical methods have been developed for estimating
haplotype-related odds ratio (OR) parameters from retrospective case-control studies (Schaid
et al., 2002; Epstein and Satten, 2003; Stram et al., 2003; Lin and Zeng, 2005; Spinka, Car-
roll, and Chatterjee, 2005), and for estimating haplotype-related relative-hazard parameters
from cohort studies (Lin, 2004; Chen and Chatterjee, 2006) or from individually matched case-
control studies nested within a cohort (Chen et al., 2004; Chen and Chatterjee, 2006). In this
article, we consider a similar problem for the analysis of matched case-control studies: we study
methods for estimating haplotype-related OR parameters accounting for phase ambiguity and
the case-control matching.
The matched case-control design is often adopted for epidemiologic studies to efficiently con-
trol for variables that confound environmental factors. Because genetic epidemiology studies
investigate joint gene-environment effects or gene-environment interactions as the norm rather
than the exception, matched case-control design is also very useful for many genetic epidemi-
ologic investigation. To implement this design, the population under study is classified into
2
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strata by disease status and values of some confounding factors chosen a priori. Then n cases
and m controls are randomly sampled from each stratum, and n and m are allowed to vary
across different strata. The analysis model of choice for this design is usually the logistic re-
gression model, and the OR parameters are estimated by maximizing the standard conditional
likelihood. For estimating haplotype-related ORs using genotype data, novel statistical meth-
ods are needed to address phase ambiguity. When n and m are large, methods for unmatched
case-control studies could yield approximately valid results when stratum-specific intercept pa-
rameters are included in the logistic regression model (Breslow and Day, 1982). When n and
m are small or the number of matching strata is large, the conditional analysis would be pre-
ferred. In fact, whenever possible, it would always be preferred to perform conditional analysis
(Breslow and Day, 1982). Kraft et al. (2005) compared several ad hoc approaches, including a
standard conditional likelihood approach but replacing haplotype-specific covariates with their
expected values conditioned on the genotype data. Because the expected values are usually not
the same as the true values, this approach usually yields biased OR estimates.
In this article, we propose two novel conditional likelihood methods for consistent estimation
of haplotype and haplotype-environment interaction effects using unphased genotype data from
matched case-control studies. We introduce the notation and model in Section 2. In Section 3,
we present the two approaches and show how they are used for assessing SNP-disease associa-
tion. In Section 4, we apply the proposed methods to the analysis of data from a collaborative
study between the National Cancer Institute (NCI) and American Cancer Society (ACS) on
the genetic susceptibility of prostate cancer. In a scenario similar to this real study, we perform
simulation studies to assess the consistency and efficiency of the two methods, to examine the
consistency of their asymptotic variance estimators, and to evaluate the robustness of the two
methods to critical assumptions. Details of these simulation studies are given in Section 5. We
make some final remarks in Section 6.
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2. Notation and Model Specification
We use H = {. . . , ha, . . . , hb, . . .} to denote the set of all possible haplotypes within a suitable
chromosome segment (e.g., haplotype block) chosen a priori. Let H = (ha, hb) denote the hap-
lotype pair that an individual carries in his/her pair of homologous chromosomes (diplotype).
The diplotype data H is usually not directly observable. Instead, the multi-locus genotype data
G, which record the pair of alleles a subject carries on the pair of homologous chromosomes
at each locus, are observed. To discern H from G, one needs to know the arrangement of
alleles, i.e., the phase information, along each individual chromosome, but such information
is not contained in G. Consequently, the same genotype data G could be compatible with
multiple diplotypes. We denote HG to be the set of all possible diplotypes consistent with the
genotype data G. Let D denote the binary case-control status, S indicate the sampling stratum
defined by matching factors, and Z be a vector of covariates. We assume that the disease risk
(penetrance) given H, Z, and S is described by the logistic regression model
p(D = 1|H,Z, S) = [1 + exp {−αs − βhXH − βzZ − γk(Z,H)}]−1 , (1)
where {eαs , s = 2, . . . , S} are stratum-specific OR parameters in reference to a baseline stratum,
eβh is a vector of haplotype-specific OR parameters in reference to a chosen baseline haplotype,
and k(Z,H) is an interaction term between Z and H. Let δij be a function taking value
one if i = j and zero otherwise. Depending on the numerical coding of XH , one can fit
for a haplotype h∗ a multiplicative model (XH = δhah∗ + δhbh∗), a dominant model (X
H =
δhah∗ + δhbh∗ − δhah∗δhbh∗), or a recessive model (XH = δhah∗δhbh∗) (e.g., Wallenstein, Hodge,
and Weston, 1998). If, for example, four haplotypes (h1, h2, h3, h4) are present in the study
population, then to fit a dominant model, one could construct XH = Xh2 where Xh2 indicates
whether a subject has a copy of haplotype h2 or not (0 or 1).
Let Ds = (Ds1, . . . , DsJs) be the vector of disease indicators for subjects j = 1, . . . , Js in
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the sth matched set, and D∗s be a permutation of Ds. We similarly define Zs, Gs, and Hs.
Let n1s be the number of cases within the s
th stratum. If the diplotype H were observed for
all subjects, then β ≡ (βh, βz, γ) could be estimated by maximizing the standard conditional
likelihood Lf =
∏
s p(Ds|n1s,Hs,Zs):
Lf =
S∏
s=1
∏
j:Dsj=1
eβhX
Hsj+βzZsj+γk(Zsj ,Hsj)∑
D∗s
∏
l:D∗sl=1
eβhX
Hsl+βzZsl+γk(Zsl,Hsl)
.
An attractive feature of this likelihood is that nuisance parameters αs fall out because the
likelihood is conditioned on their sufficient statistic {n1s}. Consequently, parameters {αs, s =
2, . . . , S} are not involved in the inference of β.
3. Semiparametric Approaches for the Estimation of OR Parameters
In this section, we present two novel conditional likelihood approaches for the estimation of β.
In the absence of phase information, we consider a novel conditional likelihood based on the
observed genotype data G,
∏
s p(Ds,Gs|n1s,Zs, S), which is a function of β and the conditional
diplotype distribution p(H|D,Z, S). We factorize this likelihood as{∏
s
p (Gs|Ds,Zs, S)
}{∏
s
p (Ds|n1s,Zs, S)
}
. (2)
The first method we propose is based only on the first part
∏
s p (Gs|Ds,Zs, S), and the sec-
ond approach utilize both parts. Both methods involve the unknown nuisance distribution
p(H|D,Z, S), which is non-identifiable from SNP genotype data without any model assump-
tions (Epstein and Satten, 2003). We thus impose two restrictions to the distribution of H
in the control population. The first one is that the haplotype distribution varies only with
a summary variable of Z and S, AZS, that takes a small fixed number of values. This as-
sumption can be formally expressed as p(ha|D = 0, Z, S) = p(ha|D = 0, AZS) ≡ f 0a (AZS)
and p(H|D = 0, Z, S) = p(H|D = 0, AZS) ≡ p0(H|AZS). We use subscript “ZS” to indi-
cate that A could be a function of both Z and S. For example, if cases and controls are
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matched on ethnicity and family history is included in Z as a risk factor, then AZS could
indicate strata defined jointly by ethnicity and family history. We assume that these control
population substrata are defined before applying the proposed methods, possibly by exam-
ining differences in haplotype frequency estimates among different candidate substrata. The
second restriction we impose is that the distribution of diplotype H follows Hardy-Weinberg
equilibrium in each control sub-population defined by AZS. That is, within each control
sub-group defined by AZS, we have p
0{H = (ha, hb)|AZS} = f 0a (AZS)f 0b (AZS) if a = b and
p0{H = (ha, hb)|AZS} = 2f 0a (AZS)f 0b (AZS) if a 6= b. Let f0(AZS) be the vector of haplotype
frequencies within stratum AZS and f
0 be the pool of vectors f0(AZS).
Under the two assumptions above, the full conditional likelihood (2) is a function of unknown
parameters β and f0. A useful result owing to the first assumption is that haplotype frequencies
for cases are free of αs and depend on S only through AZS, following a similar result in Epstein
and Satten (2003):
p(H|D = 1, Z, S) = e
βhX
H+γk(Z,H)p0(H|AZS)∑
G
∑
H∈HG e
βhXH+γk(Z,H)p0(H|AZS) ≡ p(H|D = 1, Z, AZS).
Here we also make a natural assumption that the support of genotype G is the collection of all
unique genotypes observed in cases and controls.
3.1 Method I: an Estimated Conditional Likelihood Approach
The first part of the factorization in (2),
∏
s p(Ds|Gs, n1s,Zs, S), which we denote as
LI(β, f0), is an appropriate conditional likelihood. We propose to estimate β parameters based
on LI . The disease odds associated with (G,Z, S), similar as a result in Epstein and Satten
(2003), is
θ˜(G,Z, S) =
p(Y = 1|G,Z, S)
p(Y = 0|G,Z, S) = e
αs+βzZ
∑
H∈HG
eβhX
H+γk(Z,H)p(H|D = 0, G,AZS).
6
http://biostats.bepress.com/upennbiostat/art14
The corresponding conditional likelihood LI is then
LI{β, f0} =
S∏
s=1
∏
j:Dsj=1
eβzZsj
∑
H∈HGsj e
βhX
H+γk(Zsj ,H)p(H|D = 0, Gsj, AZsjs)∑
D∗s
∏
l:D∗sl=1
eβzZsl
∑
H∈HGsl
eβhXH+γk(Zsl,H)p(H|D = 0, Gsl, AZsls)
, (3)
which has a similar form as standard conditional likelihood Lf but with eβX
H+γk(Z,H) replaced
by its expectation with respect to the distribution p0(H|G,AZS). We note that the stratum-
specific intercept αs falls out of L
I , as in the standard conditional likelihood analysis. The
conditional likelihood LI involves haplotype frequencies in controls, f0, but it does not contain
information for making inference on f0. This is because the genotype data G, which contain
the information for inferring haplotype frequencies, are conditioned out. This is analogous to
the fact that the conditional likelihood function Lf cannot be used for inferring parameters of
the covariate distribution. We propose to estimate f0 by applying the EM algorithm (Excoffier
and Slatkin, 1995) to the genotype data for controls within each substrata AZS. We then
estimate β by maximizing LI with respect to β with p0(H|AZS) fixed at its estimate. That is,
the resultant βˆ maximizes the “estimated” likelihood LI{β, fˆ0}. When there is only one case
in each matched set indexed by s1 and the haplotype distribution in controls is independent of
Z and S, the conditional likelihood (3) reduces to
LI1 =
S∏
s=1
eβzZs1
∑
H∈HGs1 e
βhX
H+γK(Zs1,H)p(H|D = 0, Gs1)∑
l=0,1 e
βzZsl
∑
H∈HGsl
eβhXH+γK(Zsl,H)p(H|D = 0, Gsl) .
This reduced likelihood LI1 takes the same form as the partial likelihood function proposed
in Chen and Chatterjee (2006), where they studied methods for haplotype analysis of nested
case-control studies assuming a Cox proportional hazards model for disease penetrance. The
asymptotic distribution of βˆ is derived in Appendix (A3). The asymptotic variance-covariance
matrix, not surprisingly, takes a similar form as that in Chen and Chatterjee (2006). Specifically,
under the null hypothesis that the disease risk is not related to any diplotype H ∈ H, one can
perform the score test using the approach of Chen et al. (2004).
3.2 Method II: a Full Conditional Likelihood Approach
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We denote the full conditional likelihood (2) as LII , which we show is free of the stratum-
specific odds ratio parameter αs and only involves β and f
0. Because subjects within each stra-
tum defined by (D,S) are independent,
∏
s p (Gs|Ds,Zs, S) can be factorized as
∏
l:Dsl=0
p(Gsl|Dsl =
0, AZsls)
∏
r:Dsr=1
p(Gsr|Dsr = 1, Zsr, AZsrs). Thus,
∏
s
p (Gs|Ds,Zs, S) =
 ∏
l:Dsl=0
∑
H∈HGsl
p0(H|AZsls)

 ∏
r:Dsr=1
∑
H∈HGsr
p(H|Dsr = 1, Zsr, AZsrs)
 ,
which is free of αs and depends only on β and f
0. Furthermore, as is shown in Appendix (A1),
p (Ds|n1s,Zs, S) =
∏
j:Dsj=1
θ(Zsj, AZsjs)∑
D∗s
∏
l:D∗sl=1
θ(Zsl, AZsls)
where θ(Z,AZS) = e
βzZ
∑
G
∑
H∈HG e
βhX
H+γk(Z,H)p0(H|AZS). Thus, LII(β, f0) is free of αs and
is a function only of OR parameters β and haplotype frequencies f0 in controls. Estimates of
(β, f0) can be obtained by maximizing logLII(β, f0).
When there is no interaction effect between Z and H (γ = 0) and the haplotype distribution
in controls is independent of Z and S (p{H|D = 0, Z, S} = p{H|D = 0}), careful examination
of LII(β, f0) reveals that the information for βz is fully contained in p(Ds|n1s,Zs, S), which
reduces to an ordinary conditional likelihood for the effect of Z as if H were not associated
with the disease risk:
p(Ds|n1s, Zs, S) =
S∏
s=1
∏
j:Dsj=1
eβzZsj∑
D∗s
∏
l:D∗sl=1
eβzZsl
.
Information for βh and f
0 is then fully contained in the part of the likelihood p(Gs|Ds,Zs, S),
which takes the same form as the retrospective likelihood (Epstein and Satten, 2003) for an
“unmatched” case-control study. The implication for this observation is that one could perform
“unconditional case-control analysis” if he/she is only interested in assessing main haplotype
effects and willing to entertain the assumption that haplotype frequencies do not vary with
environmental risk factors and matching variables. This result can be intuitively explained as
follows. If no Z were involved, this assumption simply states that the stratum factor S is not
8
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related to haplotype frequencies in cases or controls. Consequently, the most efficient analysis
would be the unconditional analysis breaking the matching. When variables Z and H are
independent in controls and do not interact with each other for determining the disease risk,
any difference in haplotype frequencies between cases and controls is not informative of the
difference in the distributions of Z between cases and controls. Consequently, the odds ratio
for Z could be estimated as if no genetic effects were present. The “conditional” analysis using,
for example, one of our proposed methods to explicitly account for matching is necessary when
it is of interest to assess haplotype-environment interaction or when the haplotype distribution
in controls depends on Z or S.
To compute the estimates of {β, f0} and obtain the asymptotic variance-covariance matrix,
one can adopt the Newton-Raphson algorithm. Because we observed that the Newton-Raphson
algorithm may fail to converge in the presence of rare haplotypes, we propose to use a one-step
approximation to the Newton-Raphson solution (one-step estimator). This one-step estimation
method leads to estimates with the same asymptotic property as the Newton-Raphson estimates
(Bickel et al., 1993). Following Epstein and Satten (2003), we re-parametrize fa(AZS) using
parameters αa(AZS) with fa = e
αa/{1 +∑J−1j=1 eαj}, where J is the total number of haplotypes
in the AZS stratum. Let α be the collection of all αa(AZS). We denote the score functions for
β and α, {∂ logLII(β, α)/∂β, ∂ logLII(β, α)/∂α}, as {l˙IIβ (β, α), l˙IIα (β, α)}. The corresponding
information matrix I(β, α) is composed of sub-matrices Iββ = −∂l˙IIβ /∂β, Iβα = −∂l˙IIβ /∂α, and
Iαα = −∂l˙IIα /∂α. Denote estimates from method I as (βˆI , αˆI). The one-step estimates, denoted
as (βˆII , αˆII), are obtained as βˆII
αˆII
 ≈
 βˆI
αˆI
+ I−1 (βˆI , αˆI)

l˙IIβ
(
βˆI , αˆI
)
l˙IIα
(
βˆI , αˆI
)
 .
We could obtain βˆII and αˆII separately to avoid the difficulty in inverting the full information
matrix I(βˆI , αˆI). Define Iˆββ = Iββ(βˆ
I , αˆI) and define Iˆβα and Iˆαα similarly. Then βˆ
II and αˆII
9
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can be obtained as
βˆII = βˆI +
(
Iˆββ − IˆβαIˆ−1αα Iˆαβ
)−1 (ˆ˙lIIβ − IˆβαIˆ−1αα˙ˆlIIα )
and
αˆII = αˆI +
(
Iˆαα − Iˆαβ Iˆ−1ββ Iˆβα
)−1 (ˆ˙lIIα − Iˆαβ Iˆ−1ββ ˆ˙lIIβ ) ,
respectively. The key to the implementation of the one-step estimator is the availability of the
consistent initial estimates (βˆI , αˆI), which are plugged into (l˙IIβ , l˙
II
α ) and I(β, α) to obtain their
consistent estimates. In the Appendix (A4), for the one-one matched case, we give analytical
formulas for score functions and the information matrix, which turn out to be remarkably
simple.
3.3 Application of Method II to Single SNP Analysis
The two conditional likelihood approaches presented above can be applied to the analysis
involving only one-locus genotype, where each allele is a “single-locus haplotype.” Of course no
phase ambiguity is involved in this scenario. Let a and A indicate the two alleles, and ρ be the
frequency of minor allele a. Under the HWE assumption and gene-environment independence
ρ = p(a|Z, S), the frequencies of genotypes AA, Aa, and aa in controls are (1 − ρ)2, ρ(1 − ρ),
and ρ2, respectively. Let G indicate genotype AA, Aa, or aa, and let XG indicate the presence
or absence of minor allele a in G. That is, XG takes value one if G = Aa or G = aa and
zero otherwise. Certainly XG could use other numerical codings as well. It is easy to see
that method I reduces to the ordinary conditional likelihood analysis. For method II, the log
likelihood logLII for the one-one matched design can be simplified as
logLII =
S∑
s=1
∑
i=0,1
Dsi{βzZsi + βhXGsi + γk(Zsi, Gsi)}
+{2(n00 + n10) + (n01 + n11)} log(1− ρ) + {2(n02 + n12) + (n01 + n11)}logρ
−
S∑
s=1
log
[∑
i=0,1
eβzZsi
{
(1− ρ)2 + eβh+γZsi(2ρ− ρ2)}] ,
10
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where (n00, n01, n02) and (n10, n11, n12) are counts of genotype AA, Aa, and aa in controls and
cases, respectively. Parameter estimates can then be obtained by maximizing logLII jointly
over (βz, βh, γ, ρ) or by applying the one-step approximation.
4. Analysis of Data from a Prostate Cancer Study
Researchers at the National Cancer Institute (NCI) and the American Cancer Society (ACS)
are collaborating to investigate the role of insulin resistance and chronic inflammation in the
development of prostate cancer using the ACS Cancer Prevention Study-II nutrition cohort
(Calle, 2002). A nested case-control study of 1, 209 prostate cancer cases and an equal number
of controls has been undertaken to evaluate the relationship between prostate cancer risk and a
number of key genes involved in the insulin signaling and chronic inflammation pathways. One
control was matched to a case on ethnicity, age within 6 months, and date of blood collection.
Because 97.0% of the study subjects were Caucasians, and because we did not have convenient
access to the ethnicity status due to data security concerns, we included the small number of
non-Caucasians in the current analysis.
We assessed whether the gene coding for tumor necrosis factor α (TNF-α) was associated
with prostate cancer risk. The current analysis focused on demonstrating the proposed methods,
and scientific results on genetic epidemiology of prostate cancer in relation to this gene will be
presented in future manuscripts. TNF-α is a protein produced by macrophages in the presence
of an endotoxin, and it has been shown to contribute to the progression of several cancers
and thus may play a role in prostate cancer progression. In this collaborative study, 5 SNPs
were genotyped in the TNF-α gene. First, we assessed the association between each SNP and
prostate cancer risk by examining the OR associated with the presence of a variant allele, using
both the standard conditional likelihood method (method I) and method II. The two methods
yielded similar ORs and confidence intervals. In particular, the presence of a minor allele at
one locus, which we named as TNF1, appeared to be significantly associated with lower risk
11
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(OR[95% CI]: 0.776[0.616, 0.980] and 0.761[0.609, 0.950] by methods I and II, respectively).
In addition, the estimates of minor allele frequencies from method II were also very similar to
those obtained by simply calculating the proportion of minor alleles in controls.
We then investigated the joint effect of SNP TNF1 and haplotypes formed by the other four
SNPs (Table 1). In particular, let Xh indicate the presence (Xh = 1) or absence (Xh = 0) of
haplotype h, and let X1 indicate the presence (X1 = 1) or absence (X1 = 0) of a minor allele
at locus TNF1. We applied methods I and II to fit the following model:
p(D = 1|Xh, X1, S) = [1 + exp {−αs − βhXh − βzX1 − γXh ×X1)}]−1 .
We note that this analysis is appropriate when TNF1 is outside of the chromosome region
spanned by the other four SNPs. Because TNF1 was in linkage disequilibrium with the other
four SNPs (correlation coefficients in controls were -0.21, -0.09, -0.14, and -0.18, respectively),
we estimated haplotype frequencies in controls for those with X1 = 0 and X1 = 1 separately.
Following the notations in Section 3, Z = X1 and AZS = X
1. In this analysis, we chose to
ignore haplotypes with estimated frequencies below 0.025%, so that the expected number of each
haplotype in the study sample was at least one in the absence of association. Nine haplotypes for
controls with Xh = 0 and 6 for controls with Xh = 1 were included in the analysis. We chose to
present results for haplotype 1122. Neither the main effect of haplotype 1122 nor its interaction
with TNF1 was significant by either method, suggesting a lack of evidence that the genomic
region spanned by the four TNF SNPs other than TNF1 may contain loci related to prostate
cancer risk. As in the single SNP analysis, the two methods yielded similar OR estimates,
although the confidence intervals by method II were slightly shorter. Because the number of
subjects with both Xh = 1 and haplotype 1122 was small (less than 4.0% in controls), the
confidence intervals (CIs) of γˆ by both methods were large. The haplotype frequency estimates
by the two methods were also very close, and the CIs by method II were slightly shorter. In
12
http://biostats.bepress.com/upennbiostat/art14
unreported analysis, we also examined the multiplicative effect of haplotype 1122 (Xh = 0, 1, or
2 according to the number of haplotype 1122 that a subject had). The results were essentially
the same with those in Table 1.
For the purpose of comparison, we also performed an analysis similar to that in Table
1 but assumed that the haplotype distribution was the same for controls with Xh = 0 or
Xh = 1. The respective OR estimates and 95% CIs for βh, βz and γ were −0.03(−0.26, 0.21),
−0.17(−0.43, 0.06), and−0.52(−1.18, 0.15) by method I and 0.05(−0.16, 0.26), −0.03(−0.28, 0.22),
and −1.09(−1.53,−0.66) by method II. We observed that method I yielded essentially the same
results as those in Table 1, but method II yielded dramatically different results. This indicated
that method II is much more sensitive to the assumption p(H|D = 0, Z, S) = p(H|D = 0).
In unreported analysis, we also evaluated the effect of haplotypes formed by all five TNF
SNPs. Haplotype 21111 appeared to be significantly associated with prostate cancer risk
(OR[95% CI] is 0.773[0.610, 0.978] by method I and 0.761[0.608, 0.953] by method II). However,
it appeared that this association was mainly due to the presence of a minor allele at the first
locus (TNF1), which in itself was shown to be significant with a similar OR.
5. Simulation Studies
We performed simulation studies to assess the proposed methods in the following aspects:
(i) the consistency of methods I and II; (ii) the relative efficiency of the two approaches; (iii)
the consistency of the asymptotic variance estimators: the asymptotic variance formula for
method I (Appendix A3), and the inverse of the information matrix as a variance-covariance
estimator for method II; and (iv) the robustness of the methods with respect to the two critical
assumptions: p(H|D,Z, S) = p(H|D,AZS) and HWE in controls with the same value for AZS.
5.1 Basic study design
We generated data for 500 one-one matched case-control pairs sampled from 500 distinct
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strata. We first generated p(Z = 1|D = 0, S) by sampling S numbers from a normal distribution
with mean minus one and variance one and then transforming them by the logistic function
exp(·)/{1 + exp(·)}. These 500 values were kept fixed in all simulations. For each simulation
study, we then generated Z for controls in each of the S strata from a Bernoulli distribution
with success probability p(Z = 1|D = 0, S). The prevalence of exposure Z was approximately
0.3 in the sampled controls. We considered the estimation of OR parameters for the main
effect of one haplotype and the interaction between this haplotype covariate and variable Z.
We considered three models for the haplotype effect: the multiplicative model, the dominant
model, and the recessive model.
To generate SNP genotype data for controls, we used 8 common haplotypes estimated from
the genotype data for all 5 SNPs in the NCI-ACS study: 11111, 21111, 11122, 11211, 12112,
11112, 11121, and 21121. Their estimated frequencies were 0.285, 0.144, 0.138, 0.111, 0.095,
0.085, 0.076, and 0.066, respectively. For each control, we generated a haplotype pair under
the assumption of HWE and then deleted phase information to obtain the SNP genotype data.
In this simulation study, we focused on assessing the main effect of haplotype “21111” and its
interaction with Z.
We generated Z for cases from the distribution
p(Z = 1|D = 1, S) = p(Z = 1|D = 0, S)e
βzZ
∑
G
∑
H∈HG e
βhX
H+γk(Z,H)p0(H)∑1
i=0 p(Z = i|D = 0, S)eβzZi
∑
G
∑
H∈HG e
βhXH+γk(Zi,H)p0(H)
.
We noted that this distribution was compatible with the penetrance function (1). This could
be shown in a way similar to that of deriving p(H|D = 1, Z, AZS). The genotype data for cases
were generated using diplotype frequencies p(H|D = 1, Z, AZS). The data were analyzed using
three methods: methods I and II using the unphased genotype data and standard conditional
logistic regression using the simulated diplotype data without phase deletion. The simulation
studies were conducted in software R and repeated 200 times.
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5.2 Results
Table 2 contains results on the consistency of the two methods and their asymptotic variance
estimators. We used 1000 matched pairs for the recessive model to compensate for the fact that
less than 1% of controls had two copies of haplotype “21111” and Z = 1. We used 500 matched
pairs for multiplicative and dominant models to save computing time. Averaged estimates for
β were sufficiently close to the true values, suggesting the consistency of the two methods. For
both methods, the averaged asymptotic standard deviations (SDs) (column SDA) are all close
to the empirical SDs for 200 β estimates (column SDE), and all the 95% confidence intervals
nearly achieve the nominal coverage probability (column “Cover”). Interestingly, comparison
of SDs for standard conditional logistic regression (column “CLREG”) and the two proposed
methods showed that method II led to the smallest SD, and that method I gave the largest SD.
That is, in this simulation study, method II, which did not use phase information, was more
efficient than the standard conditional logistic regression analysis that exploited the diplotype
data. We note, however, that these two methods were not comparable as they adopted different
likelihoods and used different data. The efficiency gain for method II over method I was most
apparent for the estimation of interaction effects and for the recessive model. Such gain,
quantified by the square of the ratio between estimated variances for methods I and II minus
quantity 1, was 103% under the null and 245% with the interaction effect OR being 1.5 (i.e.,
γ = 0.405) when the effect of haplotype “21111” was recessive. For the estimation of the main
effect βh, under multiplicative, dominant, and recessive models, the respective efficiency gain
of method II was around 16%, 27%, and 86% under the null and 21%, 35%, and 96% under
the alternative. Similar efficiency advantage of method II was also observed for the estimation
of f0 (data not shown).
We assessed the sensitivity of the two methods to the HWE assumption by allowing a partic-
ular form of departure from HWE when simulating diplotype data for controls. In particular, we
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assumed that p{H = (ha, hb)} = (1−φ)fafb+φfa, if a = b and p{H = (ha, hb)} = 2(1−φ)fafb
if a 6= b, where φ is the fixation index, with larger absolute value of φ indicating more se-
rious departure from HWE. Positive φ indicates excess homozygous diplotypes, and negative
φ indicates excess heterozygous diplotypes. It appears that both methods were insensitive
to small deviations from HWE (φ=0.05). The test sizes for β were all close to the nominal
level. The estimated coverage probabilities of the 95% confidence intervals for all parameters
were all close to 95%, although under the alternative, the coverage probabilities for βh and
frequency for haplotype “21111” were more noticeably lower than 95% (90.5% and 86.5%, re-
spectively). Nevertheless, the averaged asymptotic SDs were still close to the empirical SDs.
Table 3 displays results corresponding to φ = 0.14, which indicates serious violation of the HWE
assumption. Method I performed satisfactorily in all aspects, although the coverage probabil-
ity for the frequency of haplotype “21111” was slightly lower under the alternative (88.0%).
However, method II became problematic. Under the dominant and recessive models, the bias
in the main effect βh was intolerable. For example, the average of 200 estimates by method II
was 1.419 compared with the true value 0.405. Consequently, the confidence intervals for βh
had very poor coverage probabilities. Under the dominant model, the 95% confidence intervals
for βh and frequency of haplotype “21111” had respective coverage 62.0% and 77.5% under the
null and 52.5% and 51.0% under the alternative. Surprisingly, the averaged estimates of the
interaction effect were close to to the truth (0.405) in all scenarios.
When the assumption p(H|D = 0, Z, S) = p(H|D = 0, AZS) does not hold, we note that
the degree of bias would be similar to that when the HWE assumption is violated. This is
because p(H|D = 0, Z, S) would be the mixture of haplotype distributions in all control strata.
This mixture mostly does not follow HWE if each control stratum is at HWE but haplotype
frequencies differ among strata. Unreported simulation results confirmed this observation and
showed that both the main effect βh and the interaction effect γ could be seriously biased.
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6. Discussion
The two conditional likelihood approaches have different merits. The full conditional like-
lihood approach (method II) could yield a much more precise estimate of the haplotype-
environment interaction effect than the estimated conditional likelihood method (method II).
Method I, on the other hand, appeared to be very robust to parametric model assumptions on
the distribution of diplotypes conditioned on environmental covariates and matching factors
(namely, p(H|D = 0, Z, S) = p(H|D = 0, AZS) and HWE). Certainly these assumptions could
be relaxed to a certain extent, as suggested in the previous literature (eg., Satten and Epstein,
2004; Spinka, Carroll, and Chatterjee, 2005). For example, the HWE assumption could be re-
laxed by incorporating an unknown fixation index to allow excess homozygous or heterozygous
diplotypes (Satten and Epstein, 2004). The assumption p(H|D = 0, Z, S) = p(H|D = 0, AZS
could be partially examined by assessing whether the genotype frequency of each single SNP
varies with Z. In the situation that these assumptions seem doubtful, method I is probably
more assuring to the mind.
The robustness of method I to the two assumptions carries over to the hypothesis testing
using the Wald statistic: the size of the tests is generally close to the nominal level. In particular,
Chen et al. (2004) reported that the score test based on method I maintains the correct size
even when the HWE assumption is violated. They showed that the expectation of the score
functions for OR parameters under the null are zero even if wrong haplotype frequencies are
used. It is interesting to explore similar robust score tests in the setting of method II.
We proposed to implement method II by the one-step estimation method (Bickel et al.,
1993), which essentially yielded identical results as the Newton-Raphson algorithm. But it
does not require iteration, it only involves the inversion of sub-matrices of the full Hessian
matrix, and it saves the computing time. We implemented these methods in software R, and
the program is available upon request to the first author. For fitting a dataset with 500 matched
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pairs, this program takes approximately 1.5 minutes for method I and 30 additional seconds
for method II. The one step method could also be applied to the maximum likelihood method
of haplotype analysis for other study designs, upon the availability of an initial consistent
estimate.
The two novel methods we studied are closely related to the previous literature. The
condition likelihood in method I extends the retrospective likelihood approach in Epstein and
Satten (2003) to the matched case-control setting. In the absence of phase ambiguity, method I
reduces to the ordinary conditional likelihood analysis. In the absence of haplotype-environment
interaction and haplotype-environment dependence in controls, for estimating haplotype-related
disease risk parameters, method II reduces to the unconditional maximum likelihood method
proposed by Epstein and Satten (2003). We observed in the simulation study that method
II is much more efficient than method I for the estimation of interaction effects, particularly
under the non-multiplicative models. This observation is consistent with results in the previous
literature in the setting of unmatched case-control studies (Satten and Epstein, 2004; Spinka,
Carroll, and Chatterjee, 2005).
Methods proposed in this paper are also closely related to the work of Rathouz (2003)
and Satten and Carroll (2000). For matched case-control studies, Rathouz (2003) proposed
semiparametric efficient estimation methods for parameters in generalized linear models with
stratum-specific intercepts and missing covariates. For logistic regression models with covariates
modeled parametrically, their efficient method reduces to that in Satten and Carroll (2000). Our
method II has a similar flavor. It would be interesting to investigate theoretically whether this
full conditional likelihood approach is fully efficient under the HWE and haplotype-environment
independence assumptions and to investigate efficient approaches that make less restrictive
assumptions. Method I takes a similar form as a “suboptimal” conditional likelihood that
Rathouz (2003) studied.
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APPENDIX
To simplify the notation, we present all derivations assuming p(H|D = 0, Z, S) = P (H|D =
0), but all results apply to the situation when the distribution of H in controls depends on
AZS, that is, p(H|D = 0, Z, S) = P (H|D = 0, AZS).
A1 The derivation of p(Ds|n1s,Zs, s)
We take the support of genotype G to be the collection of all unique genotypes in the case-
control sample. Applying a result in Epstein and Satten (2003), we derived
p(D = 1|G,Z, S) = p(D = 0|G,Z, S)eαs+βzZ
∑
H∈HG
eβhX
H+γk(Z,H)p(H|D = 0, G).
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Thus, we have
p(D = 1|Z, S) =
∑
G
p(D = 1|G,Z, S)p(G|Z, S)
= eαs+βzZ
∑
G
{
p(D = 0|G,Z, S)p(G|Z, S)
∑
H∈HG
eβhX
H+γk(Z,H)p(H|D = 0, G, Z, S)
}
= p(D = 0|Z, S)eαs+βzZ
∑
G
{
p(G|D = 0, Z, S)
∑
H∈HG
eβhX
H+γk(Z,H)p(H|D = 0, G, Z, S)
}
= p(D = 0|Z, S)eαs+βzZ
∑
G
∑
H∈HG
eβhX
H+γk(Z,H)p(H|D = 0).
This leads to the result
θ(Z, S) =
p(D = 1|Z, S)
p(D = 0|Z, S) = e
αs+βzZ
∑
G
∑
H∈HG
eβhX
H+γk(Z,H)p(H|D = 0).
Let θ(Z) = eβzZ
∑
G
∑
H∈HG e
βhX
H+γk(Z,H)p(H|D = 0). Then p(Ds|n1s,Zs, S) follows.
A2 The derivation of p(G|Ds,Zs, S)
By the assumption that p(H|D = 0, Z, S) = p(H|D = 0), we have
p(H|D = 1, Z, S) = p(D = 1|H,Z, S)p(H|Z, S)/p(D = 1|Z, S)
= eαs+βzZ+βhX
H+γk(Z,H)p(H|D = 0, Z, S)p(D = 0|Z, S)/p(D = 1, Z, S)
=
eβhX
H+γk(Z,H)p(H|D = 0)∑
G
∑
H∈HG e
βhXH+γk(Z,H)p(H|D = 0) .
In particular, when γ = 0, this formula reduces to
p(H|D = 1, Z, S) = e
βhX
H
p(H|D = 0)∑
G
∑
H∈HG e
βhXHp(H|D = 0) ≡ p(H|D = 1, Z).
Thus, haplotype frequencies in cases are independent of S when those of controls are indepen-
dent of S. In the absence of haplotype-environment interaction, such frequencies are indepen-
dent of Z as well.
A3 The asymptotic property of method I
The proof largely follows that in Chen and Chatterjee (2006). Let Uβα(β, αˆ) = ∂L
I(β, αˆ)/∂β.
A standard Taylor’s series expansion of U(βˆ, αˆ) around the true parameter values (β, α) leads
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to
βˆ − β ≈ I−1ββU(β, α)− I−1ββ Iβα(αˆ− α),
where Iββ and Iβα are the large-sample limits of −∂U(β, α)/∂β and −∂U(β, α)/∂α, respectively.
Since LI(β, α) is a proper conditional likelihood function, following the standard asymptotic
theory for matched case-control studies, we have cov{U(β, α)} = Iββ, and √ncU(β, α) ∼
Normal(0, Iββ). Moreover, from standard parametric maximum likelihood inference theory, we
have
√
nc(αˆ− α) ∼ Normal{0, (Icαα)−1}, where nc is the total number of matched controls and
Icαα is the asymptotic information matrix for α (Excoffier and Slatkin, 1995).
Furthermore, U(β, α) and (αˆ − α) are asymptotically uncorrelated. The results above
show that βˆ follows an asymptotically normal distribution with mean β and variance Σ =
I−1ββ + I
−1
ββ Iβα(I
c
αα)
−1ITβαI
−1
ββ . Σ can be estimated as follows. Let Iˆββ = −∂U(β, α)/∂β|βˆ,αˆ,
Iˆβα = −∂U(β, α)/∂α|βˆ,αˆ, and Iˆcαα be the estimated information matrix for α using controls
only. Then Σ can be consistently estimated as
Σˆ = Iˆ−1ββ + Iˆ
−1
ββ Iˆβα(Iˆ
c
αα)
−1IˆTβαIˆ
−1
ββ .
Above, Iββ can also be consistently estimated as
∑S
s=1 U
s(βˆ, αˆ)
[
U s(βˆ, αˆ)
]T
, where U s is Uβα(βˆ, αˆ)
for the sth matched set.
A4 The score functions and Hessian matrix for method II
We give score functions for (β, f0) only for the one-one matching case. Let X = {XH , Z, k(Z,H)},
let E1si(·) = E(·|D = 1, Zsi), and let
Wβh,γ(Zsi, H) =
∑
G
∑
H∈HG
eβhX
H+γk(Z,H)p(H|D = 0).
Then the score functions for β are
Uβ =
S∑
s=1
[
E(X|D = 1, Gs1, Zs1)−
∑
i=0,1 E(X|D = 1, Zsi)eβzZsiWβh,γ(Zsi, H)∑
i=0,1 e
βZsiWβh,γ(Zsi, H)
]
.
23
Hosted by The Berkeley Electronic Press
Let ∆a be the number of counts (0, 1, 2) for haplotype ha. The score functions for f
0
a without
applying the restriction
∑
a f
0
a = 1 are
Uf0a =
1
f 0a
S∑
s=1
[∑
i=0,1
E(∆a|D = 1, Gsi, Zsi)−
∑
i=0,1 E(∆a|D = 1, Zsi)eβzZsiWβh,γ{Zsi, H}∑
i=0,1 e
βZsiWβh,γ{Zsi, H}
]
.
It can be shown that fˆ 0a can be obtained as f
0
aUf0a/2nc, where nc is the total number of controls
in the matched case-control sample. The score function for αa can be easily obtained from Uf0a .
The Hessian matrix also has a very simple form.
Iββ = −
S∑
s=1
[∑
i=0,1 E
1
si(XX T )eβzZsiWβh,γ(Zsi, H)∑
i=0,1 e
βzZsiWβh,γ(Zsi, H)
+ cov(XX T |D = 1, Gs1, Zs1)
−
{∑
i=0,1 E
1
si(X )eβzZsiWβh,γ(Zsi, H)
}{∑
i=0,1 E
1
si(X )eβzZsiWβh,γ(Zsi, H)
}T
{∑
i=0,1 e
βzZsiWβh,γ(Zsi, H)
}2
 ,
Iβf0 = − 1
fa
S∑
s=1
[∑
i=0,1 E
1
si(X∆T )eβzZsiWβh,γ(Zsi, H)∑
i=0,1 e
βzZsiWβh,γ(Zsi, H)
+ cov(X∆T |D = 1, Gs1, Zs1)
−
{∑
i=0,1 E
1
si(X )eβzZsiWβh,γ(Zsi, H)
}{∑
i=0,1 E
1
si(∆)e
βzZsiWβh,γ(Zsi, H)
}T
{∑
i=0,1 e
βzZsiWβh,γ(Zsi, H)
}2
 ,
and
Ifafb = −
1
fafb
S∑
s=1
[∑
i=0,1 E
1
si(∆a∆b)e
βzZsiWβh,γ(Zsi, H)∑
i=0,1 e
βzZsiWβh,γ(Zsi, H)
+
∑
i=0,1
cov(∆a∆b|D = i, Gsi, Zsi)
−
{∑
i=0,1 E
1
si(∆a)e
βzZsiWβh,γ(Zsi, H)
}{∑
i=0,1 E
1
si(∆b)e
βzZsiWβh,γ(Zsi, H)
}T
{∑
i=0,1 e
βzZsiWβh,γ(Zsi, H)
}2

−I(a = b)(fa)−2Ufa .
Iβ,f0 and If0,f0 can then be easily transformed to get Iβα and Iαα, the Hessian matrix corre-
sponding to α = {αa, a = 1, . . . , J − 1}.
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Table 1
The ASC Study: Prostate Cancer Risk Associated with the Presence of Haplotype 1122 in Reference
to its absence
Method I Method II
βˆh(95% CI) -0.03(-0.26, 0.21) -0.10(-0.31, 0.12)
βˆz(95% CI) -0.19(-0.45, 0.06) -0.22(-0.47, 0.04)
γˆ(95% CI) -0.50(-1.16, 0.16) -0.34(-1.00, 0.33)
Xh = 0 Xh = 1 Xh = 0 Xh = 1
100× fˆ0a1111(95% CI) 56.15b(53.54, 58.76) 80.66(76.80, 84.52) 56.36c(54.34, 58.38) 80.29(76.94, 83.64)
100× fˆ02111(95% CI) 17.99(15.97, 20.01) 8.39(5.68, 11.10) 17.39(15.99, 18.79) 8.38(5.67, 11.09)
100× fˆ01122(95% CI) 16.27(14.35, 18.19) 5.69(3.43, 7.95) 16.57(14.69, 18.44) 6.30(4.45, 8.16)
100× fˆ01212(95% CI) 5.13(3.96, 6.30) 1.98(0.62, 3.34) 5.63(4.74, 6.53) 2.52(1.24, 3.80)
100× fˆ01112(95% CI) 2.16(1.40, 2.92) 1.27(0.16, 2.38) 1.79(1.34, 2.23) 0.47(0.16, 0.78)
100× fˆ01121(95% CI) 1.51(0.78, 2.24) 2.01(0.63, 3.39) 1.62(1.08, 2.16) 2.04(1.00, 3.09)
100× fˆ02121(95% CI) 0.65(0.12, 1.18) -d 0.58(0.27, 0.89) -
100× fˆ02221(95% CI) 0.07(0.01, 0.21) - 0.03(0.01, 0.06) -
100× fˆ01222(95% CI) 0.05(0.01, 0.18) - 0.07(0.01, 0.33) -
a: Subscripts refer to haplotypes, with “1” representing the wild-type allele and “2” the variant allele.
b: Haplotype frequency estimates by applying EM algorithm to controls only.
c: Haplotype frequency estimates using method II.
d: Haplotype frequency estimate was less than 0.0001.
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Table 2
Consistency and Efficiency of Proposed Methods, and Consistency of Asymptotic Variance
Estimators: Simulation Studies Using 500 Matched Case-Control Pairs and 200 Repeated Runs.
CLREG Method I Method II
Model βˆ(SDE)a βˆ(SDA/SDE)b Coverd βˆ(SDA/SDE)c Coverd
Under the Null Hypothesis: βh2 = βz = γ = 0
βh2 -0.001(0.154) 0.003(0.163/0.160) 0.950 -0.005(0.150/0.146) 0.960
Multiplicative βz -0.001(0.162) -0.004(0.172/0.167) 0.965 -0.004(0.161/0.157) 0.955
γ 0.001(0.281) 0.004(0.293/0.297) 0.945 0.001(0.209/0.200) 0.960
βh2 -0.019(0.183) -0.022(0.185/0.188) 0.930 -0.010(0.164/0.163) 0.960
Dominant βz -0.011(0.170) -0.014(0.175/0.175) 0.965 -0.007(0.162/0.155) 0.965
γ 0.014(0.310) 0.024(0.332/0.329) 0.955 -0.004(0.234/0.225) 0.970
βh2 -0.005(0.380) -0.005(0.387/0.380) 0.950 -0.019(0.284/0.281) 0.955
Recessivee βz -0.002(0.110) -0.002(0.108/0.110) 0.940 -0.002(0.107/0.110) 0.930
γ 0.058(0.718) -0.058(0.742/0.718) 0.980 -0.043(0.520/0.509) 0.975
Under the Alternative Hypothesis: βh2 = 0.405, βz = 0.916, γ = 0.405
βh2 0.411(0.161) 0.409(0.170/0.169) 0.965 0.382(0.154/0.157) 0.940
Multiplicative βz 0.928(0.189) 0.930(0.187/0.190) 0.935 0.938(0.174/0.180) 0.940
γ 0.418(0.251) 0.411(0.269/0.254) 0.965 0.388(0.158/0.166) 0.935
βh2 0.413(0.194) 0.405(0.202/0.202) 0.950 0.402(0.174/0.178) 0.955
Dominant βz 0.930(0.188) 0.927(0.189/0.190) 0.940 0.927(0.174/0.177) 0.950
γ 0.413(0.300) 0.418(0.317/0.310) 0.965 0.404(0.195/0.196) 0.950
βh2 0.425(0.419) 0.425(0.386/0.419) 0.940 0.439(0.276/0.277) 0.915
Recessivee βz 0.919(0.116) 0.919(0.109/0.116) 0.930 0.918(0.109/0.113) 0.935
γ 0.464(0.658) 0.464(0.634/0.658) 0.925 0.441(0.341/0.365) 0.935
a: The mean (standard deviation) of βˆ by standard conditional logistic regression using known phase.
b: The mean (averaged estimated asymptotic/empirical standard deviation) using method I.
c: The mean (averaged estimated asymptotic/empirical standard deviation) using method II.
d: 95% coverage probabilities.
e: 1000 matched pairs were used for the recessive model.
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Table 3
Robustness to the Violation of HWE due to Excess Homozygosity (Fixation Index is 0.14): Simulation
Studies Using 500 Matched Case-Control Pairs and 200 Repeated Runs.
CLREG Method I Method II
Model βˆ(SDE)a βˆ(SDA/SDE)b Coverc βˆ(SDA/SDE)d Coverc
Under the Null Hypothesis: βh2 = βz = γ = 0
βh2 0.001(0.105) 0.001(0.128/0.125) 0.955 -0.001(0.092/0.117) 0.860
Multiplicative βz 0.010(0.122) 0.011(0.120/0.123) 0.940 0.011(0.114/0.117) 0.940
γ -0.009(0.190) -0.014(0.188/0.189) 0.955 -0.016(0.136/0.152) 0.930
βh2 0.005(0.124) 0.000(0.132/0.135) 0.955 -0.199(0.115/0.116) 0.620
Dominant βz 0.009(0.123) 0.008(0.122/0.125) 0.940 0.002(0.114/0.120) 0.925
γ -0.016(0.223) -0.014(0.238/0.241) 0.955 0.008(0.169/0.175) 0.940
βh2 -0.006(0.273) -0.006(0.270/0.273) 0.615 1.048(0.284/0.252) 0.035
Recessive βz 0.001(0.099) 0.001(0.108/0.099) 0.925 0.000(0.101/0.097) 0.985
γ -0.033(0.535) -0.033(0.443/0.535) 0.895 0.023(0.502/0.497) 0.945
Under the Alternative Hypothesis: βh2 = 0.405, βz = 0.916, γ = 0.405
βh2 0.416(0.106) 0.417(0.112/0.110) 0.935 0.440(0.088/0.106) 0.945
Multiplicative βz 0.906(0.128) 0.907(0.130/0.130) 0.950 0.877(0.120/0.122) 0.945
γ 0.412(0.182) 0.410(0.171/0.184) 0.945 0.480(0.097/0.120) 0.945
βh2 0.408(0.141) 0.401(0.142/0.148) 0.945 0.165(0.121/0.124) 0.525
Dominant βz 0.928(0.135) 0.929(0.131/0.139) 0.945 0.926(0.122/0.126) 0.945
γ 0.397(0.227) 0.393(0.224/0.241) 0.945 0.404(0.138/0.147) 0.925
βh2 0.390(0.251) 0.390(0.248/0.251) 0.825 1.419(0.272/0.260) 0.040
Recessive βz 0.910(0.110) 0.910(0.111/0.110) 0.950 0.909(0.110/0.109) 0.960
γ 0.461(0.484) 0.461(0.433/0.484) 0.885 0.454(0.338/0.385) 0.925
a: The mean (standard deviation) of βˆ by standard conditional logistic regression.
b: The mean (averaged estimated asymptotic/empirical standard deviation) using Method I.
c: 95% coverage probabilities.
d: The mean (averaged estimated asymptotic/empirical standard deviation) using Method II.
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